HealthDay on MSN4h
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke SurvivorsFor patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...
Civic Science on MSN7h
Ozempic Report Insights: Lifestyle Changes, Dining Habits, and Mental HealthThis is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Health on MSN7h
Why's It So Hard to Get a GLP-1 Prescription?However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...
Ozempic is making its presence known on menus, and the forecast for dumplings is 100% sunshine.
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback